Tag: HAVN Life Sciences - Psychedelic Alpha

Read more about the article HAVN Life Announces Retail Listing With Loblaws Company Ltd.

HAVN Life Announces Retail Listing With Loblaws Company Ltd.

Post published:October 28, 2022
Post category:Press Release

Read more about the article HAVN Life Provides Corporate Update

HAVN Life Provides Corporate Update

Post published:September 21, 2022
Post category:Press Release

Read more about the article HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments‎ and the Issuance of Shares for Debt

HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments‎ and the Issuance of Shares for Debt

Post published:August 19, 2022
Post category:Press Release

Read more about the article HAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of Convertible Debentures and Warrants

HAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of Convertible Debentures and Warrants

Post published:July 24, 2022
Post category:Press Release

Read more about the article HAVN Life Enters Supply Agreement with MPB Group Inc.

HAVN Life Enters Supply Agreement with MPB Group Inc.

Post published:June 29, 2022
Post category:Press Release

Read more about the article HAVN Life To Be Featured On Viewpoint with Dennis Quaid

HAVN Life To Be Featured On Viewpoint with Dennis Quaid

Post published:June 22, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.